EIB Backs Biovac for Africa's First Multi-Vaccine Site

The EIB Group, European Commission, and International Finance Corporation (IFC) are jointly supporting Biovac's development of Africa’s first end-to-end multi-vaccine manufacturing site. This partnership aims to strengthen vaccine production capacity in Africa, contributing to global health security and reducing reliance on external supplies. This initiative will have long-term benefits for public health in the region and potentially beyond.

Read source